OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide <italic>versus</italic> investigator's choice in relapsed or refractory mantle cell lymphoma.
Published in:
British Journal of Haematology, 2018, v. 180, n. 2, p. 224, doi. 10.1111/bjh.15025
By:
- Arcaini, Luca;
- Lamy, Thierry;
- Walewski, Jan;
- Belada, David;
- Mayer, Jiri;
- Radford, John;
- Jurczak, Wojciech;
- Morschhauser, Franck;
- Alexeeva, Julia;
- Rule, Simon;
- Cabeçadas, José;
- Campo, Elias;
- Pileri, Stefano A.;
- Biyukov, Tsvetan;
- Patturajan, Meera;
- Casadebaig Bravo, Marie‐Laure;
- Trnĕný, Marek;
- the SPRINT Trial Investigators
Publication type:
Article
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
Published in:
American Journal of Hematology, 2017, v. 92, n. 10, p. E575, doi. 10.1002/ajh.24854
By:
- Witzig, Thomas E.;
- Luigi Zinzani, Pier;
- Habermann, Thomas M.;
- Tuscano, Joseph M.;
- Drach, Johannes;
- Ramchandren, Radhakrishnan;
- Kalayoglu Besisik, Sevgi;
- Takeshita, Kenichi;
- Casadebaig Bravo, Marie-Laure;
- Zhang, Lei;
- Fu, Tommy;
- Goy, Andre
Publication type:
Article